NovoCure Limited (NVCR) Net income 2017–2026
NovoCure Limited (NVCR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$136.2MFY2026 · since FY2017: -$131.8M → -$136.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$136.2M | +19.4% |
| FY2025 | -$169.0M | +18.4% |
| FY2024 | -$207.0M | -122.6% |
| FY2023 | -$93.0M | -60.3% |
| FY2022 | -$58.0M | -392.8% |
| FY2021 | $19.8M | +374.0% |
| FY2020 | -$7.2M | +88.6% |
| FY2019 | -$63.6M | -3.1% |
| FY2018 | -$61.7M | +53.2% |
| FY2017 | -$131.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice